NHS

Neuberger High Yield Strateg

+$13.3M

Net Activity

Institutions Holding

53

Popularity Rank

#5847

Avg Weight

0.10%

Total Value

$43.2M

Ownership Trend

53 institutions currently hold NHS, with 33 net buyers and 18 net sellers this quarter.

Institutional Moves

Institutional Moves (Q1 2026)

Majority Increased

Based on recent trading activity

Net Selling Institutions

18

Net Buying Institutions

33

Key Holders

View all 53 holding institutions

Quarterly Activity

Recent Activity

+$31.8M

Total Buy Value

$17.1M

Total Sell Value

New buy17
Trim12
Add16
Sold out6

33

Net Buyers

18

Net Sellers

Insider Trading (Form 4)

Form 144 Pre-Sale Notices

No Form 144 planned sale filings in the last 90 days

Beneficial Ownership (13D/13G)

1

Active 5%+ Holders

Data as of 2026-07-14
Reporting PersonTypeFiling Date% of Class
First Trust Portfolios L.P.13G/A2026-07-1420.5%

View all Schedule 13D/13G filings

Material Events (8-K)

No Form 8-K filings for this ticker

FAQ

Who are the top institutional investors holding NEUBERGER HIGH YIELD STRATEG (NHS)?
Major stakeholders currently include Morgan Stanley ($4.3M), Cable Car Capital, LP ($3.6M), Guggenheim Capital LLC ($3.5M). Based on the latest 13F filings, there are a total of 53 tracked investment funds and institutions maintaining positions in NHS.
What is the overall institutional sentiment toward NHS recently?
Institutional sentiment appears Bullish (Net Buying). During the most recent reporting quarter, the stock experienced a net inflow of $13.3M, driven by 33 managers accumulating shares while 18 reduced their exposure.
Which institutions have been selling or reducing their NHS positions?
In the latest period, 12 funds trimmed their holdings, and 6 managers completely exited their positions. The aggregate reported sell value was $17.1M.
Are there any notable investors adding NHS to their portfolios?
Yes, buying activity remains notable. 17 institutions opened new positions in {ticker}, and 16 existing holders added to their shares. The total reported buy value for the quarter amounted to $31.8M.

Related Stocks